HeartBeam, Inc. (BEAT) Form 10-Q — May 13, 2026
HeartBeam, Inc. reported a net loss of $4.7 million for the quarter ended March 31, 2026, compared to a net loss of $5.484 million in the same period of 2025. The decrease in net loss is primarily due to a reduction in research and development expenses, which fell by 32% to $2.37 million from $3.492 million in the prior year. This reduction is attributed to lower product development and consulting expenses, as well as the full vesting of milestone awards by the end of 2025.
Key figures
- Revenue
- 0
- Total Debt
- 3294
- Cash Position
- 2039
- Shares Outstanding
- 55506835
- Net Proceeds From ATM
- 1515
- Overallotment Gross Proceeds
- 1500
- Gross Proceeds From Underwritten Offering
- 11500
Price after filing
Close on the filing date to close N calendar days later (from $1.01). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.